ARVO 2016
    Ocular Pathology/Oncology

    In this interview from ARVO 2016, Dr. Rajesh Rao discusses use of precision medicine to sequence orbital and ocular adnexal lymphomas. This method analyzes the genetic profile of each tumor, targeting actionable mutations shared with other cancers, giving patients with rare cancers immediate therapeutic avenues. Additionally, profiling can be done on stored tissue so that uncommon mutations can be assessed without waiting for a sample from a current patient.